H.R. 6664 · 118th Congress

Innovation in Pediatric Drugs Act of 2023

Introduced on Dec 7, 2023 by Anna G. Eshoo (D-CA-16). 9 cosponsors, 1 of them from another party. Latest action (Dec 8, 2023): Referred to the Subcommittee on Health.

Stage
Introduced
Introduced
Dec 7, 2023
Cosponsors
9
1 from the other party
Policy area
Health
Open in the Congress explorerCongress.govAlert me

Progress

The furthest stage the measure reached. Simple and concurrent resolutions do not go to the President.

  1. Introduced
  2. 2Reported by committee
  3. 3Passed one chamber
  4. 4Passed both chambers
  5. 5Sent to the President
  6. 6Became law

Official title

To encourage innovation in the development of pediatric drugs, and for other purposes.

Subjects

  • Child health
  • Congressional oversight
  • Drug safety, medical device, and laboratory regulation
  • Government information and archives
  • Government studies and investigations
  • Health programs administration and funding
  • Medical research
  • Prescription drugs
  • Research administration and funding

Summary

The Congressional Research Service has not summarized this measure yet.

Sponsor and cosponsors

Cosponsors by party as of the day they signed on. Original cosponsors signed on the day of introduction.

Anna G. EshooD-CA-16Sponsor

Democrats · 8

Republicans · 1

Roll calls

Recorded votes on the measure. Most measures move by voice vote or unanimous consent, which record no individual positions.

No recorded roll call on this measure: it moved by voice vote or unanimous consent, or has not reached the floor.

History

Every action as published, oldest first. Roll calls link to how each member voted.

  1. Dec 7, 2023Introduced in House
  2. Dec 7, 2023Introduced in House
  3. Dec 7, 2023 · HouseReferred to the House Committee on Energy and Commerce.
  4. Dec 8, 2023 · HouseReferred to the Subcommittee on Health.

Committees

Committees and subcommittees the measure was referred to.

Agencies in its committees' jurisdiction

Analisa's mapping of committee jurisdiction to federal agencies; the bill may touch others, or none of these.

Who lobbied on it

Organizations whose lobbying reports (LD-2) name this measure. Spending is what they reported for those quarters on all issues, not on this measure alone.

  1. PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA7 reports
    $31M reported (all issues)
  2. Dana-Farber Cancer Institute5 reports
    $348.9K reported (all issues)Federal contractor: DANA-FARBER CANCER INSTITUTE, INC.$933K in contracts, FY2026AI match · 100%
  3. NATIONWIDE CHILDREN'S HOSPITAL, INC.5 reports
    $275K reported (all issues)
  4. National Minority Quality Forum Action Network5 reports
    $240K reported (all issues)
  5. American Academy of Pediatrics4 reports
    $748K reported (all issues)Federal contractor: AMERICAN ACADEMY OF PEDIATRICS$442.6K in contracts, FY2026AI match · 100%
  6. BIOTECHNOLOGY INNOVATION ORGANIZATION4 reports
    $6.7M reported (all issues)
  7. GSK (fka GLAXOSMITHKLINE INC.)4 reports
    $4.8M reported (all issues)
  8. HARMONY BIOSCIENCES, LLC4 reports
    $600K reported (all issues)Federal contractor: HARMONY BIOSCIENCES LLC$614.4K in contracts, FY2026AI match · 100%
  9. NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS (N.A.C.H.)4 reports
    $5.7M reported (all issues)
  10. NOVARTIS CORPORATION4 reports
    $6M reported (all issues)Federal contractor: NOVARTIS PHARMACEUTICALS CORPORATION$36.2M in contracts, FY2026AI match · 100%
  11. The Leukemia & Lymphoma Society4 reports
    $1M reported (all issues)
  12. The Nemours Foundation - a Florida not-for-profit Corporation4 reports
    $802.2K reported (all issues)
  13. AMERICAN COLLEGE OF RHEUMATOLOGY3 reports
    $260K reported (all issues)
  14. American Academy of Family Physicians3 reports
    $3M reported (all issues)Federal contractor: AMERICAN ACADEMY OF FAMILY PHYSICIANSAI match · 99%
  15. EVERYLIFE FOUNDATION FOR RARE DISEASES3 reports
    $100K reported (all issues)
  16. RARE DISEASE COMPANY COALITION3 reports
    $400K reported (all issues)
  17. AMERICAN PSYCHIATRIC ASSOCIATION2 reports
    $513.9K reported (all issues)Federal contractor: AMERICAN PSYCHIATRIC ASSOCIATION$645K in contracts, FY2026AI match · 100%
  18. BRIDGEBIO PHARMA INC.2 reports
    $330K reported (all issues)
  19. ASSOCIATION FOR CLINICAL ONCOLOGY1 report
    $90K reported (all issues)
  20. Children's Hospital and Health System, Inc.1 report
    $90K reported (all issues)
  21. Fulcrum Therapeutics1 report
    $60K reported (all issues)

Reports filed in 2023, 2024, 2025.

Sources and method

Every figure on this page traces to these records.

  • Bill status: bills and resolutions, sponsors, actions, subjects and CRS summaries (U.S. Government Publishing Office (GovInfo), from Congress.gov (Library of Congress))GovInfo Bill Status bulk data (Congress.gov; summaries by the Congressional Research Service) · data current to Oct 9, 2026 · loaded Oct 9, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Members of Congress, their terms, committees and identifiers (The @unitedstates project (from the Biographical Directory of the U.S. Congress, the House and the Senate))unitedstates/congress-legislators: legislators, committees and current committee membership · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: CC0 1.0 (public domain dedication)
  • House roll-call votes (Office of the Clerk, U.S. House of Representatives)Office of the Clerk, U.S. House of Representatives, roll-call vote records · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Senate roll-call votes and DW-NOMINATE scores (Voteview (UCLA Department of Political Science))Lewis, Jeffrey B., Keith Poole, Howard Rosenthal, Adam Boche, Aaron Rudkin, and Luke Sonnet (2026). Voteview: Congressional Roll-Call Votes Database. https://voteview.com/ · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Free to use with the required citation
  • Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives)Clerk of the House, Lobbying Disclosure Act filings (organizations only; lobbyists' names are not loaded) · data current to Oct 9, 2026 · loaded Oct 9, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Positions are shown only where a roll call recorded them; voice votes and unanimous consent record none.
  • Money and votes are shown side by side; neither explains the other.